Stock listing
A2N6P0 Stock Price, News, Filings & Events — Kodiak Sciences Inc
Selected listing: A2N6P0 · LSX · EUR · DE
This page tracks Kodiak Sciences Inc's A2N6P0:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2N6P0:LSX. A2N6P0:LSX is the stock-level entry point for investors researching Kodiak Sciences Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2N6P0:LSX
- Asset type
- Stock
- Market cap
- $2.37B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Kodiak Sciences Inc A2N6P0:LSX stock context
This page tracks Kodiak Sciences Inc's A2N6P0:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2N6P0:LSX. A2N6P0:LSX is the stock-level entry point for investors researching Kodiak Sciences Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Kodiak Sciences Inc
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results
August 13, 2026
Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema
August 10, 2026
Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflamma...
August 6, 2026
Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference
May 28, 2026
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results
May 7, 2026
Research Kodiak Sciences Inc
Kodiak Sciences Inc investor report
Review AI stock analysis and investor report context for A2N6P0:LSX.
Kodiak Sciences Inc company profile
View the public company page for Kodiak Sciences Inc on 6ix.
Kodiak Sciences Inc news
Read company news and market updates connected to Kodiak Sciences Inc.
Kodiak Sciences Inc investor events
Find investor webinars, events, and replay context for Kodiak Sciences Inc.
Alternate listings
KOD:NASDAQ
US · USD
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
K27:GETTEX
DE · EUR
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
A2N6P0:LS
DE · EUR
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
KOD:BIVA
MX · MXN
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
KOD:BMV
MX · MXN
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
KOD:BOATS
US · USD
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
K27:TRADEGATE
DE · EUR
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
K27:FWB
DE · EUR
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
K27:DUS
DE · EUR
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
K27:MUN
DE · EUR
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.
K27:SWB
DE · EUR
Alternate listing for Kodiak Sciences Inc; the primary context on this page is A2N6P0:LSX.